They verified in vitro that deficiency of IL-18 could suppress the cytotoxicity of NK cells and CD8+ T cells, indicating that the absence of IL-18 is likely to mediate the IFN-γ pathway during tumorigenesis in ESCC and lead to AR in anti-tumor immunity (121). This evidence concerns the gene CD8A and neoplasm.